
Tobraza 11mg Tablet XR
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Tofacitinib (11mg)
Overview Tobraza 11mg Tablet XR
Rheumacin 11mg Extended-Release Tablets are indicated for moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication reduces joint pain, tenderness, and swelling by suppressing inflammation, and helps to retard the progression of bone and joint deterioration. Rheumacin 11mg Extended-Release Tablets may be used alone or in conjunction with other therapies. These tablets can be administered with or without food, ideally at the same time daily. Dosage is determined by your physician based on your individual needs and other medications you are taking. Always adhere to your doctor's prescribed regimen. Discontinuing treatment prematurely could exacerbate your condition. Common adverse effects include upper respiratory infections, headaches, diarrhea, and nasopharyngitis. Less frequent, but potentially serious side effects, such as blood clots and gastrointestinal perforations, require immediate medical attention. Report any concerns regarding side effects to your doctor. Pre-treatment blood work may be necessary, and treatment should not commence if you have an active infection. Inform your doctor before initiating treatment if you have or have had tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or a history of pulmonary or deep vein thrombosis. Rheumacin 11mg Extended-Release Tablets can increase susceptibility to infections or worsen existing ones; avoid contact with individuals exhibiting contagious illnesses (e.g., chickenpox, measles, influenza). This medication is contraindicated in patients under 18 years of age and during pregnancy or breastfeeding unless deemed clinically necessary by your physician. Regular medical monitoring may be required.
Uses of Tobraza 11mg Tablet XR
Managing rheumatoid, psoriatic, and ankylosing spondylitis, plus ulcerative colitis.
Major Benefits of Tobraza 11mg Tablet XR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Tobraza 11mg Extended-Release Tablet whole; avoid crushing, chewing, or breaking it. While you can take it with or without food, consistency is key—take it at the same time each day.
Common Side effects of Tobraza 11mg Tablet XR:
- Upper respiratory tract infection
- Headache
- Diarrhea
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Tobraza 11mg Tablet XR:
Consume this medication according to your doctor's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Tobraza 11mg Extended-Release Tablet can be administered with or without food, however, consistent timing is recommended.
How Tobraza 11mg Tablet XR works:
Tobraza XR 11mg tablets function as a Janus kinase inhibitor, suppressing Janus kinase enzyme activity. This consequently reduces immune system activity and inflammation characteristic of rheumatic conditions and ulcerative colitis.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between alcohol and Tobraza 11mg Extended-Release Tablets.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tobraza 11mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Tobraza 11mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Extended-release Tobraza 11mg tablets typically do not impair driving ability.
KidneyCAUTION
Extended-release Tobraza 11mg tablets require careful administration in individuals with advanced renal impairment. Dosage modification of Tobraza 11mg extended-release tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Extended-release Tobraza 11mg tablets require careful administration in individuals with advanced hepatic impairment. Dosage modification for Tobraza 11mg extended-release tablets might be necessary. Physician consultation is advised.
What if you forget to take Tobraza 11mg Tablet XR :
Should you forget a Tobraza 11mg Tablet XR dose, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tobraza 11mg Tablet XR
| Label | Value |
|---|---|
| Chemical Type | Pyrrolopyrimidine Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Behavioral Class | JAK inhibitors |
